Developing a Robust and Scalable Platform for AAV8 Production.

No abstract is available for this paper.

• Publication year

  2025

• Venue

  Journal of Biotechnology

• Publication date

  2025-09-09

• Fields of study

  Medicine, Engineering

• Identifiers
  DOI 10.1016/j.jbiotec.2025.09.002PMID 40935180
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A two-pass anion-exchange chromatography strategy for enrichment of full capsids in manufacturing of adeno-associated viral vectors

  2025cited by this paper
• Enhancing sanitization for AVB Sepharose resin in AAV vector purification.

  2025cited by this paper
• Consecutive Affinity and Ion-Exchange Chromatography for AAV9 Vectors Purification

  2025cited by this paper
• Chromatography in Downstream Processing of Recombinant Adeno‐Associated Viruses: A Review of Current and Future Practises

  2025cited by this paper
• Separation of full and empty adeno-associated virus particles using a novel multi-modal anion exchange membrane.

  2025cited by this paper
• Towards a Platform Chromatography Purification Process for Adeno‐Associated Virus (AAV)

  2025cited by this paper
• Combining steric exclusion with anion exchange - development of a universal and scalable adeno-associated virus downstream process.

  2025cited by this paper
• Rational downstream development for adeno-associated virus full/empty capsid separation - A streamlined methodology based on high-throughput screening and mechanistic modeling.

  2024cited by this paper
• A robust and flexible baculovirus-insect cell system for AAV vector production with improved yield, capsid ratios and potency

  2024cited by this paper
• Purification of AAV8 through a scalable two-step monolithic chromatography approach.

  2024cited by this paper
• Structural characterization and epitope mapping of the AAVX affinity purification ligand

  2024cited by this paper
• A Novel and Simplified Anion Exchange Flow‐Through Polishing Approach for the Separation of Full From Empty Adeno‐Associated Virus Capsids

  2024cited by this paper
• Biolayer interferometry for adeno-associated virus capsid titer measurement and applications to upstream and downstream process development

  2024cited by this paper
• Optimization of Culture Media and Feeding Strategy for High Titer Production of an Adenoviral Vector in HEK 293 Fed-Batch Culture

  2024cited by this paper
• Adeno-associated virus as a delivery vector for gene therapy of human diseases

  2024cited by this paper
• Recent advances in upstream process development for production of recombinant adeno‐associated virus

  2023cited by this paper
• Various AAV Serotypes and Their Applications in Gene Therapy: An Overview

  2023cited by this paper
• Viral Vectors in Gene Therapy: Where Do We Stand in 2023?

  2023cited by this paper
• Large-scale purification of functional AAV particles packaging the full genome using short-term ultracentrifugation with a zonal rotor

  2023cited by this paper
• Mammalian Stable Cell Platforms for Recombinant Adeno-associated Virus (rAAV) Production: Development Strategies and their Impact on Viral Productivity.

  2023cited by this paper
• Process economics evaluation and optimization of adeno‐associated virus downstream processing

  2023cited by this paper
• Critical challenges and advances in recombinant adeno‐associated virus (rAAV) biomanufacturing

  2023cited by this paper
• Challenges in scaling up AAV-based gene therapy manufacturing.

  2023cited by this paper
• Enrichment of adeno‐associated virus serotype 5 full capsids by anion exchange chromatography with dual salt elution gradients

  2023cited by this paper
• Optimization of rAAV capture step purification using SO3 monolith chromatography

  2023cited by this paper
• The downstream bioprocess toolbox for therapeutic viral vectors.

  2023cited by this paper
• Tuning mobile phase properties to improve empty and full particle separation in adeno‐associated virus productions by anion exchange chromatography

  2023cited by this paper
• Comprehensive Comparison of AAV Purification Methods: Iodixanol Gradient Centrifugation vs. Immuno-Affinity Chromatography

  2023cited by this paper
• Concentration of clarified pool by single‐pass tangential flow filtration to improve productivity of protein A capture step: Impact of clarification strategies

  2023cited by this paper
• A Combined Ultrafiltration/Diafiltration Process for the Purification of Oncolytic Measles Virus

  2022cited by this paper
• High-efficiency purification of divergent AAV serotypes using AAVX affinity chromatography

  2022cited by this paper
• AAV process intensification by perfusion bioreaction and integrated clarification

  2022cited by this paper
• Viral Vectors for the in Vivo Delivery of CRISPR Components: Advances and Challenges

  2022cited by this paper
• Manufacturing challenges and rational formulation development for AAV viral vectors.

  2021cited by this paper
• HEK293 Cell Line as a Platform to Produce Recombinant Proteins and Viral Vectors

  2021cited by this paper
• Removal of empty capsids from adeno-associated virus preparations by multimodal metal affinity chromatography.

  2021cited by this paper
• Development of a scalable and robust AEX method for enriched rAAV preparations in genome-containing VCs of serotypes 5, 6, 8, and 9

  2021cited by this paper
• Adeno-Associated Virus-Based Gene Therapy for Lifelong Correction of Genetic Disease

  2020cited by this paper
• Adeno-associated virus capsid assembly is divergent and stochastic

  2020cited by this paper
• Development and Clinical Translation of Approved Gene Therapy Products for Genetic Disorders

  2019cited by this paper
• Severe Toxicity in Nonhuman Primates and Piglets Following High-Dose Intravenous Administration of an Adeno-Associated Virus Vector Expressing Human SMN

  2018cited by this paper
• Highly Efficient Ultracentrifugation-free Chromatographic Purification of Recombinant AAV Serotype 9

  2018cited by this paper
• Universal Method for the Purification of Recombinant AAV Vectors of Differing Serotypes

  2017cited by this paper
• A scalable method for the production of high-titer and high-quality adeno-associated type 9 vectors using the HSV platform

  2016cited by this paper
• Optimization and scale-up of cell culture and purification processes for production of an adenovirus-vectored tuberculosis vaccine candidate.

  2016cited by this paper
• High AAV vector purity results in serotype- and tissue-independent enhancement of transduction efficiency

  2010cited by this paper
• Identification of factors that contribute to recombinant AAV2 particle aggregation and methods to prevent its occurrence during vector purification and formulation.

  2005cited by this paper

• No citing papers are available for this paper.